1. Home
  2. Stocks
  3. Smspharma Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Sms Pharmaceuticals Share Price SMS Pharmaceuticals

    Small Cap
    ₹207.45
    -0.9 (-0.43%)
    28 April, 2024 09:28 BSE: 532815 NSE: SMSPHARMAISIN: INE812G01025

    Start SIP in SMS Pharmaceuticals

    Start SIP

    SMS Pharmaceuticals Performance

    Day Range

    • Low 206
    • High 210
    ₹ 207

    52 Week Range

    • Low 79
    • High 219
    ₹ 207
    • Open Price209
    • Previous Close208
    • Volume158164

    SMS Pharmaceuticals Share Price

    • Over 1 Month +15.73%
    • Over 3 Month +65.96%
    • Over 6 Month +75.06%
    • Over 1 Year +150.85%

    SMS Pharmaceuticals Key Statistics

    P/E Ratio 45.3
    PEG Ratio 0.1
    Market Cap Cr 1,756
    Price to Book Ratio 3.8
    EPS 0.5
    Dividend 0.1
    Relative Strength Index 60.72
    Money Flow Index 54.63
    MACD Signal 10.3
    Average True Range 10.33
    SMS Pharmaceuticals Financials
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 161167135149
    Operating Expenses Qtr Cr 133139109126
    Operating Profit Qtr Cr 29282723
    Depreciation Qtr Cr 8888
    Interest Qtr Cr 6666
    Tax Qtr Cr 4343
    Net Profit Qtr Cr 121298
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 527
    Operating Expenses Annual Cr 467
    Operating Profit Annual in Cr 55
    Depreciation Cr 32
    Interest Annual Cr 22
    Tax Annual Cr 1
    Net Profit Annual Cr 4
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 22
    Cash from Investing Activity Annual Cr -30
    Cash from Financing Annual Activity Cr -32
    Net Cash Flow Annual Cr -39
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 495
    Fixed Assets Annual Cr 445
    Total Non Current Assets Annual Cr 504
    Total Current Assets Annual Cr 411
    Total Assets Annual Cr 914
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 58
    ROE Annual % 1
    ROCE Annual % 4
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 11
    Sign Up to Know More
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 161167135149
    Operating Expenses Qtr Cr 132139109126
    Operating Profit Qtr Cr 29282623
    Depreciation Qtr Cr 8888
    Interest Qtr Cr 6666
    Tax Qtr Cr 4343
    Net Profit Qtr Cr 111296
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 527
    Operating Expenses Annual Cr 468
    Operating Profit Annual in Cr 55
    Depreciation Cr 32
    Interest Annual Cr 22
    Tax Annual Cr 1
    Net Profit Annual Cr -7
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 22
    Cash from Investing Activity Annual Cr -30
    Cash from Financing Annual Activity Cr -32
    Net Cash Flow Annual Cr -39
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 461
    Fixed Assets Annual Cr 445
    Total Non Current Assets Annual Cr 469
    Total Current Assets Annual Cr 411
    Total Assets Annual Cr 880
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 54
    ROE Annual % -2
    ROCE Annual % 4
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 11
    Sign Up to Know More
    Invest in SMS Pharmaceuticals

    SMS Pharmaceuticals Technicals

    EMA & SMA

    Current Price
    ₹207.45
    -0.9 (-0.43%)
    pointer
    • Bullish Moving Average
    • ___
    • 13
    • Bearish Moving Average
    • ___
    • 3
    • 20 Day
    • ₹200.97
    • 50 Day
    • ₹181.94
    • 100 Day
    • ₹161.99
    • 200 Day
    • ₹141.01
    • 20 Day
    • ₹201.13
    • 50 Day
    • ₹178.70
    • 100 Day
    • ₹151.98
    • 200 Day
    • ₹135.94

    SMS Pharmaceuticals Resistance and Support

    PIVOT
    ₹207.77
    Resistance
    First Resistance 209.88
    Second Resistance 212.32
    Third Resistance 214.43
    RSI 60.72
    MFI 54.63
    MACD Single Line 10.30
    MACD 9.21
    Support
    First Resistance 205.33
    Second Resistance 203.22
    Third Resistance 200.78

    SMS Pharmaceuticals Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 204,305 9,661,583 47.29
    Week 327,084 15,945,345 48.75
    1 Month 519,167 20,273,465 39.05
    6 Month 642,562 22,418,990 34.89

    SMS Pharmaceuticals Result Highlights

    SMS Pharmaceuticals Synopsis

    NSE-Medical-Generic Drugs

    Sms Pharmaceuticals is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 522.05 Cr. and Equity Capital is Rs. 8.47 Cr. for the Year ended 31/03/2023. SMS Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 14/12/1987 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L24239TG1987PLC008066 and registration number is 008066.
    Market Cap 1,756
    Sales 613
    Shares in Float 2.96
    No of funds 8
    Yield 0.14
    Book Value 3.55
    U/D Vol ratio 2.1
    LTDebt / Equity 24
    Alpha 0.28
    Beta 1.01

    SMS Pharmaceuticals

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 64.67%64.32%64.32%64.32%
    Mutual Funds 1.98%
    Foreign Portfolio Investors 0.17%0.59%0.6%0.67%
    Individual Investors 27.93%29.22%29.07%29.04%
    Others 5.25%5.87%6.01%5.97%

    SMS Pharmaceuticals Management

    Name Designation
    Mr. Ramesh Babu Potluri Chairman & Managing Director
    Mr. Vamsi Krishna Potluri Executive Director
    Mr. Sarath Kumar Pakalapati Independent Director
    Mr. Sharvan Kudaravalli Independent Director
    Mr. Sarvepalli Srinivas Independent Director
    Dr.(Mrs.) Neelaveni Thummala Independent Director

    SMS Pharmaceuticals Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    SMS Pharmaceuticals Corporate Action

    Date Purpose Remarks
    2024-02-08 Quarterly Results & Preferential issue
    2023-11-08 Quarterly Results
    2023-08-08 Quarterly Results
    2023-05-24 Audited Results & Final Dividend
    2023-02-09 Quarterly Results
    Date Purpose Remarks
    2023-09-22 FINAL Rs.0.30 per share(30%)Final Dividend
    2022-09-23 FINAL Rs.0.30 per share(30%)Final Dividend

    SMS Pharmaceuticals MF Shareholding

    Name Amount(cr)
    Quant Momentum Fund Regular Growth 1,357
    Quant Healthcare Fund Regular Growth 265

    SMS Pharmaceuticals FAQs

    What is Share Price of SMS Pharmaceuticals ?

    SMS Pharmaceuticals share price is ₹207 As on 28 April, 2024 | 09:14

    What is the Market Cap of SMS Pharmaceuticals ?

    The Market Cap of SMS Pharmaceuticals is ₹1756.1 Cr As on 28 April, 2024 | 09:14

    What is the P/E ratio of SMS Pharmaceuticals ?

    The P/E ratio of SMS Pharmaceuticals is 45.3 As on 28 April, 2024 | 09:14

    What is the PB ratio of SMS Pharmaceuticals ?

    The PB ratio of SMS Pharmaceuticals is 3.8 As on 28 April, 2024 | 09:14

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.